Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown bluebird bio Inc. BLUE

Alternate Symbol(s):  BLUEV

bluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.


Top institutional share ownership of bluebird bio Inc

Name Shares Shares % change Value Value % change
XBI - SPDR(R) S&P(R) Biotech ETF 10,924,275 78.1% $52,983 -13.6%
VGHCX - Vanguard Health Care Fund Investor Shares 6,140,000 0.0% $22,288 -54.0%
Wellington Management Group Llp 6,140,000 0.0% $25,420 -14.6%
Tang Capital Management Llc 5,910,687 281.3% $24,470 225.5%
BlackRock Inc. 5,813,340 -0.4% $24,066 -15.0%
Vanguard Group Inc 3,506,909 -40.8% $14,518 -49.5%
Renaissance Technologies Llc 2,810,000 198.9% $11,633 155.2%
Baker Bros. Advisors Lp 2,499,715 0.0% $10,349 -14.6%
Millennium Management Llc 2,488,818 169.7% $10,304 130.3%
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 2,117,029 7.4% $8,765 -8.3%

Top institutional buyers of bluebird bio Inc

Name Shares % change Value % change Shares Value
Citadel Advisors Llc 514.6% 424.8% 996,382 $4,125
Tang Capital Management Llc 281.3% 225.5% 5,910,687 $24,470
Renaissance Technologies Llc 198.9% 155.2% 2,810,000 $11,633
Millennium Management Llc 169.7% 130.3% 2,488,818 $10,304
XBI - SPDR(R) S&P(R) Biotech ETF 78.1% -13.6% 10,924,275 $52,983
LABU - Direxion Daily S&P Biotech Bull 3X Shares Direxion Daily S&P Biotech Bull 3X Shares 53.8% -29.3% 1,067,937 $3,877
Federated Hermes, Inc. 26.2% 7.8% 1,157,322 $4,791
Geode Capital Management, Llc 12.2% -4.3% 1,257,612 $5,206
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 7.4% -8.3% 2,117,029 $8,765
VEXMX - Vanguard Extended Market Index Fund Investor Shares 2.1% -12.9% 968,064 $4,008

Top institutional sellers of bluebird bio Inc

Name Shares % change Value % change Shares Value
State Street Corp -86.1% -88.2% 1,825,101 $7,556
NAESX - Vanguard Small-Cap Index Fund Investor Shares -51.7% -76.6% 846,728 $4,107
Vanguard Group Inc -40.8% -49.5% 3,506,909 $14,518
QASCX - Federated MDT Small Cap Core Fund Class A Shares -31.2% -23.2% 744,078 $3,014
Credit Suisse Ag/ -27.3% -37.9% 1,603,353 $6,638
Goldman Sachs Group Inc -11.4% -24.3% 1,855,880 $7,684
Jpmorgan Chase & Co -8.5% -21.9% 1,705,489 $7,060
BlackRock Inc. -0.4% -15.0% 5,813,340 $24,066

Information provided by Fintel.io